9:15am ET
Health and Healthcare
Is Rigel Getting Enough From Bristol-Meyers?
Rigel Pharmaceuticals and Bristol-Myers Squibb announced Monday morning that they have entered into a collaboration agreement.
Chris Lange BMY Coverage Page 30
Chris Lange 10:10am ET
Health and Healthcare
5 Top Credit Suisse Health Care Stock Picks to Buy for 2015
24/7 Wall St. reviewed the new Credit Suisse Top Picks for 2015 report, and here are five of the top health care picks.
10:00am ET
Health and Healthcare
Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines
If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today.
10:05am ET
Health and Healthcare
5 Top Pharmaceutical Stock Picks for 2015
In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: Applied Materials, Broadcom, Cisco, Genworth, SanDisk and More
Thursday's top analyst upgrades, downgrades and initiations include Applied Materials, Broadcom, Cisco Systems, Genworth Financial and SanDisk.
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Thursday, October 16, 2014.
8:55am ET
Health and Healthcare
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.
8:30am ET
Health and Healthcare
3 Likely Biotech Buyout Candidates
A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could be of the blockbuster variety.
10:45am ET
Health and Healthcare
Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014
A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of 2014
2:44pm ET
Health and Healthcare
ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms
ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had approved the drug ELIQUIS, as a treatment for Deep Vein Thrombosis and Pulmonary Embolisms. Each…
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include Alcatel-Lucent, Apple, FireEye, JDSU Uniphase and solar stocks.
10:15am ET
Health and Healthcare
Upcoming Binary Events Could Lift These Health Care Stocks Much Higher
In a new report, the analysts at health care boutique Leerink highlight numerous upcoming catalysts for some top stocks in the sector. Catalysts may move the stocks sharply either way, depending on…
8:30am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Lululemon, Microsoft, NBG, Twitter, Whole Foods and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 5, 2014. They include Apple, Lululemon, Microsoft, NBG, Twitter and Whole Foods.
8:20am ET
Health and Healthcare
Why You Buy Big Pharma If the Market Crashes
A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is large cap pharmaceuticals. Here are their top large cap pharmaceuticals to buy…
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Cisco, Kinder Morgan, Rackspace, Twitter and More
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Thursday, May 15, 2014. They include Cisco Systems, Kinder Morgan, Rackspace, Twitter and L-3 Communications.